Mef Christina Nilbert

Mef Christina Nilbert serves as an Adjunct Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her contact information lists a Copenhagen address (Blegdamsvej 3, 2200 København N) and university email. With 116 total research outputs documented, her work demonstrates sustained academic engagement in clinical oncology research.

Nilbert specializes in hereditary bowel cancer (arvelig tarmcancer), focusing on prevention and screening for Lynch syndrome (HNPCC), which affects approximately 3,500 Danes annually. Her research emphasizes early detection's critical role in treatment success. Primary keywords associated with her work include Cancer, Cancer Diseases, and Colorectal Cancer, reflecting her concentration on gastrointestinal malignancies within medical genetics and preventive oncology frameworks.

Her recent publications (2021-2023) reveal three dominant research trajectories: First, investigations into hereditary colorectal cancer genetics and screening protocols; second, analyses of cancer care disruptions during the COVID-19 pandemic; and third, studies on cancer immunotherapy mechanisms and healthcare disparities. These articles appear in high-impact journals including The Lancet family, Journal of Clinical Medicine, and Human Genetics, demonstrating international recognition of her work.

Nilbert actively collaborates across European institutions, as evidenced by multi-country studies on colorectal cancer screening outcomes. Her research has been referenced in clinical guidelines and policy documents, picked up by multiple news outlets, and widely shared on academic platforms like Mendeley. While no formal awards are explicitly listed, the policy impact and clinical guideline references indicate significant professional influence in oncology practice.

Her work bridges clinical practice, genetic research, and public health policy, particularly regarding cancer prevention strategies. The substantial citation counts (up to 68 Scopus citations for recent Lancet publications) confirm her contributions to advancing colorectal cancer understanding and treatment protocols across European healthcare systems.